A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.
Deutsch
S I
SI
Psychiatry Service, Veterans Administration Medical Center, Washington, D.C. 20422.
Mastropaolo
J
J
Schwartz
B L
BL
Rosse
R B
RB
Morihisa
J M
JM
D005971:Glutamates / Q000502:physiology*; D005998:Glycine / Q000494:pharmacology*; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000502:physiology*; D012559:Schizophrenia / Q000503:physiopathology*; D009435:Synaptic Transmission
D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D005998:Glycine